Calcium signaling plays a pivotal role in many functions of the cell at the molecular level. It is particularly important in neurons for expression of genes essential for learning and memory formation, and disruption of calcium signaling can cause neuronal cell death leading to loss of memory (reviewed in West et al., [@B57]; Berridge, [@B9]). In neurons, changes in intracellular calcium levels cause changes in membrane potential that control neuronal excitability (reviewed in Berridge, [@B8]). Many studies have demonstrated that calcium signaling can regulate gene expression at the transcription level (reviewed in Zhang et al., [@B63]; Alonso and Garcia-Sancho, [@B2]). However, a number of recent studies are revealing an intriguing new post-transcriptional level of regulation by calcium signaling: at the level of alternative pre-mRNA splicing. It has been observed that an alteration of the intracellular calcium level can lead to differential expression of numerous alternative exons (reviewed in Xie, [@B58]). These observations have very significant implications in terms of the dynamic control of alternative splicing.

More than 95% of the protein-coding genes in humans undergo alternative splicing to provide a varied proteome (Pan et al., [@B45]; Wang et al., [@B56]). Studies carried out during the last three decades have generated a wealth of information that contributes to our understanding of cell type- and developmental stage-specific regulation of alternative splicing. However, we know surprisingly little about how cells respond to stimuli to modulate alternative splicing. Only a handful of studies have explored the underlying mechanisms by which calcium signaling regulates alternative splicing. A review published in 2008 provided a comprehensive summary of calcium-mediated splicing control (Xie, [@B58]). In this review, the author compiled a list of nearly 20 alternative exons that were demonstrated to undergo calcium-mediated regulation. Next, he discussed the potential mechanisms of calcium-mediated splicing control using three well-studied examples. Finally, he speculated how calcium signaling influences neuronal functions and disease development. Since 2008, several more studies have been published, one of which demonstrated an exciting new level of regulation. The current review is aimed at providing an in-depth discussion of the molecular mechanisms of the dynamic control of alternative splicing regulated by calcium signaling. An important goal is to draw attention to this under-explored area of research. Building on information gained from a limited number of studies, we will point out important future directions.

Regulation of Alternative Splicing
==================================

Production of protein-coding mRNAs in mammalian cells involves two tightly coupled processes: transcription of the pre-mRNA from the gene and pre-mRNA processing, which consists of 5′ end capping, removal of introns, and polyadenylation of the 3′ end of the pre-mRNA. RNA processing factors are loaded onto the pre-mRNA co-transcriptionally, some through the C terminal domain (CTD) of the largest subunit of RNA polymerase II (RNA Pol II) (Misteli and Spector, [@B42]; Hirose and Manley, [@B22]; Lewis and Tollervey, [@B33]; Phatnani et al., [@B46]; Rosonina and Blencowe, [@B48]; Bentley, [@B5]; Egloff and Murphy, [@B16]). The classical view of alternative splicing regulation involves short conserved RNA sequences (enhancers and silencers) found in exons and introns of the pre-mRNA molecule, where splicing regulators such as serine/arginine proteins (SR proteins) and heterogeneous ribonucleoproteins (hnRNPs) bind (reviewed in Black, [@B10]; Jurica and Moore, [@B25]). Upon binding to an enhancer or silencer sequence, the splicing regulators either recruit the spliceosome, the basal splicing machinery, to or prevent the spliceosome from interacting with a particular splice site to regulate the associated alternative exon. Many splicing regulators are tissue-specific and hence are thought to be important in providing developmental stage-specific and functional isoforms of proteins for a particular tissue (Black, [@B10]; Grosso et al., [@B19]).

In addition to regulation by splicing factors, alternative splicing can be controlled by the rate of transcription as was first shown by cell transfection experiments. A change in the rate of RNA synthesis provides a change in the secondary structure of the pre-mRNA, which in turn affects the splicing event (Eperon et al., [@B17]). This was confirmed when different levels of alternative exon inclusion were observed for the same gene using promoters of different strengths to drive transcription. To explain the effects on alternative splicing by transcription, two models have been proposed in the literature: the recruitment model and the kinetic coupling model. The recruitment model suggests that splicing regulators are recruited to pre-mRNA through their association with the transcription machinery, in particular the CTD of Pol II, to regulate splicing choices, whereas the kinetic model suggests that splicing is controlled by the rate of elongation of Pol II. The slower rate of transcription elongation allows more time for the usage of weak splice sites (reviewed in Kornblihtt, [@B28]; Allo et al., [@B1]; Luco et al., [@B36]).

The rate of elongation of transcription is thought to be controlled by chromatin structure and the level of compaction of the intragenic regions. The following recent studies support an emerging idea that chromatin structure and histone modifications are major contributors in regulation of alternative splicing events (Allo et al., [@B1]; Luco et al., [@B36]). First, nucleosomes were found to be enriched on exons as compared to introns by analysis using the deep sequencing technique in combination with computational predictions (reviewed in Kaplan, [@B26]; Kornblihtt et al., [@B29]; Schor et al., [@B49]). The general hypothesis is that the nucleosomes provide a "roadblock or speed bump" for RNA Pol II elongation, which in turn provides more time for the splicing machinery to recognize alternative exons (Allo et al., [@B1]; Luco et al., [@B36]). In addition to the exon definition concept (Berget, [@B6]), where the splicing machinery recognizes intron--exon boundaries by physically interacting with the splice sites, this is thought to provide another mode of control at the DNA level for splice site recognition. Support for this hypothesis came from the observation that there is an enrichment of RNA Pol II at alternatively spliced exons in comparison to constitutive exons, thereby providing the splicing machinery more time to access weak splice sites present at the alternative splice sites (Brodsky et al., [@B12]).

Secondly, chromatin immunoprecipitation (ChIP) studies indicate that exons are differentially marked with specific histone modifications such as trimethylation of lysine 36 of histone 3 (Kolasinska-Zwierz et al., [@B27]; Spies et al., [@B54]). Thirdly, studies have demonstrated that specific histone marks can recruit splicing factors to the transcription site. For example, H3K4me3 recruits the U2 snRNP, a component of the spliceosome, via the CHD1 protein that interacts with the histone mark (Sims et al., [@B53]). In addition, H3K9me3 recruits hnRNPs through the HP1 proteins in *Drosophila* (Piacentini et al., [@B47]). These studies indicate that histone modifications can have a direct impact on splicing factor recruitment. Lastly, a very recent study indicates that Hu proteins, upon binding to their target sequences on the pre-mRNA, influence the acetylation status of histones H3 and H4 leading to a localized change in transcription elongation rate that further impacts exon skipping of at least two alternative exons (Zhou et al., [@B64]).

Calcium and Splicing
====================

Several studies have shown that disturbance of the physiological balance of calcium can contribute to alterations of alternative splicing events, especially in neuronal cells which have the most diverse RNA population (Xie and Black, [@B59]; Black and Grabowski, [@B11]; An and Grabowski, [@B3]; Lee et al., [@B31]; Schor et al., [@B50]). In each of these studies, depolarization was induced in cells with introduction of high extracellular potassium, which triggers calcium signaling by opening voltage-dependent calcium channels (Figure [1](#F1){ref-type="fig"}). An increase in internal calcium level causes skipping of exon 5 and exon 21 of NMDA receptor type 1 (NMDAR1) in hippocampal neurons (Han et al., [@B21]; An and Grabowski, [@B3]; Lee et al., [@B31]) as well as the STREX exon of the BK channel in GH3 pituitary cells (Xie and Black, [@B59]). These two splicing events, which are regulated by calcium signaling, have been studied in much detail and the results have provided important insights into how splicing regulation by calcium signaling can influence neuronal functions and diseases (Xie, [@B58]). In the case of the STREX exon of the BK channel, the regulated inclusion of the exon is thought to fine-tune the electrical activity of neurons (Xie, [@B58]). It has been shown that inclusion of the exon increases the sensitivity of the BK channels to voltage and calcium, providing a feedback loop regulatory mechanism (Li et al., [@B35], [@B34]; Xie, [@B58]; and references therein). In the case of NMDAR1, the inclusion or exclusion of exons 5 and 21 affects the localization and membrane trafficking of the NMDA receptor. This localization and trafficking in turn regulates the synaptic strength to stabilize the neuronal firing rate (homeostatic plasticity in neurons) (Lee et al., [@B31]; Li et al., [@B35]; and references therein).

![**Stimulation of a cell using various drugs can increase or decrease intracellular calcium by affecting various channels and pumps associated with calcium influx**. Increase in intracellular calcium activates calcium/calmodulin-dependent kinases, which influence splicing and/or localization of several splicing factors. These splicing factors can in turn regulate splicing by binding to CaRREs or UAGG motifs in the pre-mRNA. In addition, CaMK can phosphorylate protein kinases A and C, which feed into the downstream MAPK pathway, eventually phosphorylating ERK. Phosphorylated ERK plays a role in hyperacetylation of histones H2B, H3, and H4, which affects splicing by controlling the rate of transcription. CaMK also increases trimethylation of histone H3K36 at specific exons, although the mechanism by which CaMK does it is not known. The increase in trimethylation of histone H3K36 can directly affect splicing by recruiting splicing factors.](fnins-05-00141-g001){#F1}

Treatment of neurons by various drugs increases intracellular calcium levels by affecting calcium channels and pumps. Agonists of NMDA receptors, such as NMDA, and glutamate can increase calcium influx through the NMDA receptors, whereas antagonists such as MK801 can inhibit the influx of calcium through NMDA receptors. Opening of L-type calcium channels can be inhibited by use of pharmacological agents such as nifedipine, nimodipine, and verapamil (Xie, [@B58]; Yoneyama et al., [@B61]; Figure [1](#F1){ref-type="fig"}). Thapsigargin increases intracellular calcium by inhibiting the sarco/endoplasmic reticulum calcium pump, whereas use of dantrolene can inhibit the release of the calcium from the sarco/endoplasmic reticulum (Yoneyama et al., [@B61]) (Figure [1](#F1){ref-type="fig"}). In addition to these two genes, it has been shown that increasing calcium in the cell by using any of these pharmacological agents affects the changes in splice site selection for many genes (for a complete list see Table 1 in the review by Xie, [@B58]). Also, an exon-array performed on human neuroblastoma IMR-32 cells after depolarization with potassium chloride at different time points or after treatment with thapsigargin identified a number of genes that showed changes in splicing and transcript levels. Splicing changes were observed in mRNAs of genes such as potassium channels, neuroendocrine secretory proteins and metabolic enzymes (McKee et al., [@B40]).

Calcium and RNA Elements
========================

It is thought that just like the RNA elements in exons and introns where specific splicing regulators bind to regulate the inclusion or skipping of the exon, there are specific short conserved RNA sequences under the regulation of calcium. The current working theory is that increased intracellular calcium levels result in the activation of calcium/calmodulin-dependent kinase IV (CaMK IV), which regulates splice site selection through specific RNA elements named CaMK IV responsive RNA elements (CaRREs) (Ares, [@B4]; Lee et al., [@B31]; Xie, [@B58]). Two such CaRRE sequences, CACAUNRUUAU (N: any nucleotide, R: purine) and GUGGUAGA, have been identified (Xie et al., [@B60]; Lee et al., [@B31]; Xie, [@B58]). Importantly, when these CaRREs were inserted into a mini-gene reporter, the mini-gene alternative splicing was regulated by CaMK IV activity (Xie and Black, [@B59]; Xie et al., [@B60]; Lee et al., [@B31]). Other than the CaRREs, a distinct UAGG motif in the pre-mRNA has been shown to be required for depolarization-mediated splicing regulation. The UAGG motif-mediated splicing regulation can be inhibited by KN93, a calcium/calmodulin-dependent kinase inhibitor (An and Grabowski, [@B3]). In addition, KN93 and nifedipine, an L-type calcium channel blocker, were shown to block the exclusion of the STREX exon (thought to be under CaRRE control) caused by potassium chloride-mediated depolarization (Xie and Black, [@B59]; Xie et al., [@B60]). Lastly, cerebella of CaMK IV heterozygous mice showed increased STREX exon inclusion (Xie et al., [@B60]).

The mechanism by which CaMK IV influences specific RNA elements still remains an open question. One theory is that an increase in the calcium level activates CaMK IV, which eventually regulates splicing through these specific RNA elements in the pre-mRNA (CaRREs and UAGG). This is supported by the fact that the observed changes in splicing after increases in the intracellular calcium level can be inhibited in most of these cases by the use of either CaMK inhibitors or by other inhibitors that affect calcium levels in the cell \[for a complete list see Table 1, Xie, [@B58])\]. Although the detailed molecular mechanisms remain largely unknown on how CaMK levels influence splicing through the CaRRE RNA elements, a hint came from the studies of the UAGG motifs. In this case, hnRNP A1 was found to bind to these specific motifs in pre-mRNA and eventually influence splice site selection in neurons (An and Grabowski, [@B3]). Subsequent studies demonstrated that hnRNP L is the splicing factor that binds to a CaRRE RNA element influencing splice site selection (Yu et al., [@B62]). This regulation of hnRNP L on the CaRRE1 RNA elements was further shown to be dependent on phosphorylation of hnRNP L, which can be induced by CaMK IV as shown in *in vitro* assays using hnRNP L and CaMK IV purified from mammalian cells (Yu et al., [@B62]). A SELEX analysis indicated that a "CA" repeat motif is sufficient for the CaMK IV-mediated regulation of alternative splicing through hnRNP L (Li et al., [@B34]).

Interestingly, the CaMK IV-hnRNP L cascade may also modulate alternative splicing of a non-neuronal gene, CD45 (PTPRC). Alternative splicing of the CD45 transcript is tightly regulated during B cell development. In early peripheral lymphocytes, exons 4, 5, and 6 are included, while at later stages of B cell development, none of the three exons are included (Ogimoto et al., [@B44]). Several studies demonstrated that splicing regulation of exons 4 and 6 is mediated by hnRNP L, polypyrimidine tract-binding protein (PTB)-associated splicing factor (PSF), and hnRNP LL (Melton et al., [@B41]; Topp et al., [@B55]). Treatment of early stages of B cells with ionomycin, an ionophore which increases intracellular calcium, led to skipping of all of these alternative exons (Ogimoto et al., [@B44]). It remains to be determined whether there exist CaRRE elements where hnRNP L could potentially bind and regulate splicing of these exons. However, an exonic splicing silencer (ESS) that has been identified to be bound by hnRNP L and PSF is indeed CA-rich, similar to the CaRRE elements (Melton et al., [@B41]).

It is highly likely that many additional calcium responsive RNA elements remain to be identified. The recently developed high-throughput technologies will undoubtedly be very helpful in this regard. Presumably, these elements are under the influence of calcium signaling and can be bound by different splicing regulators in regulation of the expression of the alternative exons with which they are associated (Figure [1](#F1){ref-type="fig"}).

Calcium and Splicing Factors
============================

How does calcium signaling influence the expression of splicing regulators themselves? Recent studies appear to reveal a theme for this regulation. Changes in calcium levels regulate cellular localization of a number of RNA-binding proteins (RBPs). For example, cortical neurons depolarized by treatment with potassium chloride were shown to have an increased localization of the splicing factor hnRNPA1 in the nucleus (An and Grabowski, [@B3]). Interestingly, for a number of RBPs, the change in cellular localization is the consequence of regulated alternative splicing. A clear example is Fox-1/A2BP1, where exon 19 inclusion is repressed when neuronal cells are depolarized by potassium chloride (Lee et al., [@B30]). The skipping of exon 19 causes a frame shift in the protein, which leads to a more nuclear localization of *Fox-1/A2BP1* protein (Lee et al., [@B30]). Recently, a genome-wide analysis of mice with a central nervous system-specific gene depletion of *Rbfox1* (A2BP1) revealed splicing changes in multiple transcripts that encode proteins important for synaptic functions and neuronal excitation (Gehman et al., [@B18]). Another example is exon III of the Tra2*beta*1 transcript, which appears to be a more complicated story. When rats were treated with pilocarpine, a drug that functions as an agonist of muscarinic acetylcholine receptor and elevates calcium levels in the cell, complex results that are suggestive of a cell-specific differential response to calcium level changes were obtained. The treatment led to a reduced inclusion of exon 3 of Tra2*beta*1 in the hippocampus and increased inclusion in the brain cortex (Daoud et al., [@B14]). In a subsequent study from the same group, it was shown that treatment of primary cortical neurons with thapsigargin as well as pilocarpine increased accumulation of the Tra2*beta*1 protein in the cytoplasm (Daoud et al., [@B15]). Furthermore, translocation of Tra2*beta*1 to the cytoplasm was also observed in ischemic induction, which increases the intracellular calcium levels. Interestingly, these treatments led to splicing changes of a downstream target (Daoud et al., [@B15]). Taken together, these studies strongly suggest that alterations in intracellular calcium levels may alter the localization of many of the spliceosomal components in neurons. Such changes can lead to alterations in splice site selection of downstream target genes that are regulated by these splicing factors.

Splicing change as a result of altered calcium level was also observed with transcripts of other splicing factors. However, in these cases, it is not clear if altered splicing leads to localization changes of the resulting proteins. Intron 6 in the pre-mRNA encoding Ania-6 (cyclin L1) was shown to be retained when calcium levels were increased with the use of glutamate in striatal neurons. Paradoxically, potassium chloride depolarization that also increases calcium levels led to less intron retention (Berke et al., [@B7]; Sgambato et al., [@B51]). Furthermore, exon 3 of hnRNP H3 and exon 2 of RNP-S1 were shown to be skipped when cortical neurons were depolarized by potassium chloride (An and Grabowski, [@B3]).

Calcium Levels Affect Splicing by Regulating Chromatin Modifiers
================================================================

Recently, various studies have indicated that calcium signaling can influence chromatin modification, which in turn influences splice site selection. For example, an increase in intracellular calcium by depolarization using potassium chloride induces acetylation of H2B in the hippocampus of rats (Maharana et al., [@B38]). The elevated level of acetylation is reversed by addition of KN93, a CaMK inhibitor, suggesting that the acetylation of H2B requires CaMK (Maharana et al., [@B38]). The acetylation of H2B is also blocked by U0126, a specific inhibitor targeting ERK phosphorylation, suggesting that the increased acetylation is dependent on ERK phosphorylation. ERK is a known target for phosphorylation by CaMK; however, the mechanism by which ERK acetylates H2B remains unknown (Maharana et al., [@B38]). Furthermore, the treatment of rat hippocampal neurons with NMDA increases calcium influx, and activates the protein kinase A (PKA) or protein kinase C (PKC) pathway, which enhances ERK-dependent acetylation of Histone H3 (Levenson et al., [@B32]; Chandramohan et al., [@B13]). These data suggest that an increase in intracellular calcium levels can influence the acetylation levels of histones (Figure [1](#F1){ref-type="fig"}).

Changes of acetylation levels of histones by intracellular calcium signaling may lead to splicing pattern changes. It has been shown that cells treated with trichostatin A (TSA), a potent inhibitor of histone deacetylation, exhibit changes in mini-gene splicing (Nogues et al., [@B43]). In addition, studies carried out using yeast indicate that hyperacetylation of H3 by histone deacetylase (HDAC) depletion can delay the release of U2 snRNP, and perturb the assembly of spliceosome components (Gunderson et al., [@B20]). Recently an exon-array study showed that in HeLa cells treated with sodium butyrate (NaB), a potent HDAC inhibitor, 683 genes showed changes in splice site selection, including Tau, which is expressed in the central nervous system and associated with fronto-temporal dementia and Parkinson's disease (Hnilicova et al., [@B23]).

Depolarization by potassium chloride induces hyperacetylation of histones H3 and H4 globally in N2A cells and this hyperacetylation is reversed when cells are treated with normal media suggesting that global hyperacetylation is a direct consequence of increased intracellular calcium (Schor et al., [@B50]). This depolarization and recovery coincide with the alternative splicing of NCAM exon 18, which is skipped when cells are depolarized and included after recovery (Schor et al., [@B50]). ChIP studies showed an increase in H3K9ac in the intragenic chromatin region between exons 17 and 19 in response to depolarization (Schor et al., [@B50]). These data suggest that hyperacetylation of histones in response to increases in calcium affects the splice site selection of exon 18. This idea was further supported by the use of TSA, which mimicked the results of depolarization (Schor et al., [@B50]).

H3K36-Me3 marks have been shown to differ at constitutive and alternative exons. H3K36-Me3 marks are found at the 5′ ends of the exons and enrichment of these methyl marks correlates with increases in alternative exon inclusion (Hon et al., [@B24]; Kolasinska-Zwierz et al., [@B27]). H3K36-Me3 can recruit PTB, a splicing regulator, to the pre-mRNA through the chromatin binding protein MRG15 (Luco et al., [@B37]). Recruitment of splicing machinery at a weak alternative splice site assists in the inclusion of the weak exon (Allo et al., [@B1]; Luco et al., [@B36]). Calcium signaling could also affect methylation of this histone mark, as it was shown that depolarization by potassium chloride also increases H3K36-Me3 at distal exons of the NCAM gene in hippocampal neurons, but the mechanism by which calcium signaling achieves this is not clear (Schor et al., [@B50]).

Data obtained from these studies indicate that an increase in calcium signaling could affect chromatin modifications, which may influence alternative splicing. It is tempting to speculate that in addition to the direct effects on RBPs, this might be another mechanism by which calcium regulates alternative splicing in neurons indirectly (Figure [1](#F1){ref-type="fig"}).

An intriguing new study demonstrates that exon 5 splicing of CD45 pre-mRNA is modulated during development as a consequence of chromatin modification (Shukla et al., [@B52]). This study shows that CTCF, a zinc-finger DNA binding protein, binds to the exon 5 region of the CD45 gene, slowing down transcription by providing a pausing of RNA Pol II. This allows for exon 5 inclusion at the early stages of lymphocyte development. During maturation of lymphocytes, CTCF binding is perturbed due to increased methylation on DNA in a region where CTCF binds to exon 5, leading to exon 5 skipping (Shukla et al., [@B52]). Given that expression of exon 5 of CD45 was shown to respond to cellular calcium level changes, it will be interesting to investigate whether calcium signaling affects the methylation status of DNA at exon 5, thereby modulating the splicing of exon 5 of the CD45 pre-mRNA.

Perspective
===========

All of the studies discussed above point in the direction that changes in calcium signaling can play a major role in alternative splicing in neurons and other cell types. This could possibly be a molecular mechanism by which cells control the dynamic expression of exons that are important for their development and function. The calcium levels in neurons are under "homeostatic control" and disruption of the normal calcium level in neurons leads to disruption of neuronal functions and disease development (reviewed in Marambaud et al., [@B39]). Genome-wide exon arrays are now available and could be a useful tool in identifying the groups of genes whose alternative splicing is regulated by calcium signaling. With the advent of newer techniques like deep sequencing and genome-wide siRNA libraries with the augmentation of bioinformatic tools, it is time to study the effect of calcium-regulated alternative splicing and its role in physiological development and disease states at the genome-wide level. It is conceivable that expression of many alternative exons is subject to calcium signaling and that the dynamic regulation of these exons involves numerous distinct RNA elements and RBPs that interact with these RNA elements. Rules of calcium signaling-regulated alternative splicing will emerge from genome-wide studies.
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